Researcher
Rik
- Keywords:Medicine
- Disciplines:Natural sciences
Affiliations
- Hematology (Department)
Member
From1 Jul 2012 → Today - Hematology (Research group)
Member
From1 Oct 2003 → Today - Clinical sciences (Department)
Member
From8 Apr 2019 → Today - Clinical sciences (Department)
Member
From1 Jan 2014 → 20 Oct 2022 - Laboratory of Molecullar and Cellular Therapy (Research group)
Member
From28 Feb 2013 → 1 Oct 2019 - Immunology and Microbiology (Department)
Member
From1 Dec 2006 → 31 Dec 2013 - Immunology and Microbiology (Department)
Member
From1 Dec 2003 → 30 Sep 2006
Publications
1 - 10 of 56
- Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Authors: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pages: 1172-1177 - Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms(2023)
Authors: Guillermo Ortí, Luuk Gras, Nienke Zinger, Maria Chiara Finazzi, Katja Sockel, Marie Robin, Edouard Forcade, Daniele Avenoso, Nicolaus Kröger, Jürgen Finke, et al.
Pages: 628-638 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Authors: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pages: 249-255 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Authors: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pages: 112-121 - Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1)(2022)
Authors: Meletios A Dimopoulos, Paul G Richardson, Nizar J Bahlis, Sebastian Grosicki, Michele Cavo, Meral Beksaç, Wojciech Legieć, Anna M Liberati, Hartmut Goldschmidt, Andrew Belch, et al.
Pages: 403-414 - Improvement of transfusion practice and reduction in red blood cell utilization in Belgian hospitals(2022)
Authors: Jana Vanden Broeck, Katrien Beeckman, Evelyne Van Gastel, Luc De Keersmaecker, Timothy Devos, Christiane Gérard, Lucien Noens, Dominique Putzeys, Karin Van Poucke, Margareta Haelterman, et al.
Pages: 259-267 - Validation of a PCR-based next-generation sequencing approach for the detection and quantification of minimal residual disease in acute lymphoblastic leukemia and multiple myeloma using gBlocks as calibrators(2021)
Authors: Jona Van der Straeten, Wouter De Brouwer, Emmanuelle Kabongo Kanjinga, Marie-Françoise Dresse, Karel Fostier, Rik Schots, Ivan Van Riet, M.H.C. Bakkus
Pages: 599-611 - Efficacy of high-dose anakinra in refractory macrophage activation syndrome in adult-onset Still's disease(2020)
Authors: Sofia Ajeganova, Ann De Becker, Rik Schots
Pages: 1-9 - Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes(2020)
Authors: Ingrid Segers, Erlisa Bardhi, Ileana Mateizel, Ellen Van Moer, Rik Schots, Greta Verheyen, Herman Tournaye, Michel De Vos
Pages: 2026-2036 - Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation(2020)
Authors: Simone Cesaro, Gloria Tridello, Steffie van der Werf, Peter Bader, Gerard Sociè, Per Ljungman, Grant McQuaker, Stefano Giardino, Duygu Uckan-Cetinkaya, Achilles Anagnostopoulos, et al.
Pages: 110-116